AzTrials
AzTrials

DehydrationLIV-D2ONCT06414291

Rehydration Efficiency During Ad-libitum Fluid Intake

A study testing Plain Water, Liquid IV Hydration Multiplier and Liquid IV Sugar Free in people with Dehydration, run by Arizona State University at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

It is well established that rehydration with a carbohydrate-electrolyte solution is more effective in comparison to plain water. This is primarily based on the sodium-glucose co transporter, based on which the world health organization has based its oral rehydration solution recommendations. Read more about this study

Who is it for?
Ages 18 to 60 yearsHealthy volunteers can take part
Conditions the study is for
Dehydration
What is being tested?
Plain Water, Liquid IV Hydration Multiplier and Liquid IV Sugar Free
Type of treatment
Injection or infusion
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
20 participants
Where
1 siteUnited States
Study dates
21 May 2024to 3 Dec 2024
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 60 years
  • All sexes
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • Age 18-60 years
  • Training at least 2 times per week
  • stable weight for the last 2 months (fluctuation less than 5 pounds)

Who cannot join

  • Night shifting work
  • Thyroid medication
  • Bariatric surgery
  • Cardiovascular disease
  • Renal disease
  • Hepatic disease
  • Participating in another study at the same time
  • Bodyweight over 110 pounds

Trial locations and contacts

1 site in 1 country.

United States1 site
  • Interdisciplinary Science and Technology Building 8

    Phoenix, Arizona, 85004

Other trials in United States

About this study

It is well established that rehydration with a carbohydrate-electrolyte solution is more effective in comparison to plain water. This is primarily based on the sodium-glucose co transporter, based on which the world health organization has based its oral rehydration solution recommendations. Also, rehydration with a solution that includes sodium and glucose plasma osmolality should not drop as much as it happens during rehydration with water. As a result, we should have higher fluid intake due to higher thirst perception and lower urinary output due to higher levels of vasopressin.

The present study aims to examine the effectiveness of a electrolyte-glucose drink on rehydration following exercise-induced dehydration.

Conditions
Dehydration
Being tested
Plain Water, Liquid IV Hydration Multiplier, Liquid IV Sugar Free
Medical subject headings
Dehydration

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Plain WaterOther

    Plain water without calories, sweetener, or electolytes

  • Liquid IV Hydration MultiplierOther

    Drink with 22 grams of carbohydrate, 1020 milligrams of sodium, and 760 milligrams of potassium per liter. Hydration multiplier liquid IV

  • Liquid IV Sugar FreeOther

    10 grams of carbohydrate, 1060 milligrams of sodium, and 760 milligrams of potassium per liter. Sugar free Liquid IV

Study groups in NCT06414291
Study groupRoleWhat they receive
WaterPlacebo comparatorRehydration with low mineral content bottle water
Receives: Other: Plain Water
Carbohydrate Electrolyte solutionExperimentalDrink with 22 grams of carbohydrate, 1020 milligrams of sodium, and 760 milligrams of potassium per liter. Hydration multiplier liquid IV
Receives: Other: Liquid IV Hydration Multiplier
Low Sugar electrolyte solutionExperimental10 grams of carbohydrate, 1060 milligrams of sodium, and 760 milligrams of potassium per liter. Sugar free Liquid IV
Receives: Other: Liquid IV Sugar Free

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Total fluid intake

    Total amount of fluid ingested

    Measured: 4 hours of rehydration

  2. Net fluid balance

    amount of water retained during the rehydration period

    Measured: at 4 hours of the rehydration period

  3. Net fluid balance

    amount of water retained during the rehydration period

    Measured: at 3 hours of the rehydration period

  4. Rate of absorption

    The rate of Deuterium appearance in the blood during 30 minutes of rehydration

    Measured: during the first 30 minutes of rehydration

  5. Rate of absorption

    The rate of Deuterium appearance in the blood during 60 minutes of rehydration

    Measured: during the first 60 minutes of rehydration

  6. Rate of absorption

    The rate of Deuterium appearance in the blood during 120 minutes of rehydration

    Measured: during the first 120 minutes of rehydration

  7. Rate of absorption

    The rate of Deuterium appearance in the blood during 180 minutes of rehydration

    Measured: during the first 180 minutes of rehydration

  8. Rate of absorption

    The rate of Deuterium appearance in the blood during 240 minutes of rehydration

    Measured: during the first 240 minutes of rehydration

  9. Cumulative urine output

    Total amount of urine output during rehydration

    Measured: during the first 3 hours of rehydration

  10. Cumulative urine output

    Total amount of urine output during rehydration

    Measured: during the first 4 hours of rehydration

Secondary outcomes (7)
  1. Plasma copeptin

    Plasam Copeptin during rehydration

    Measured: at 30 minutes, 1 hour, 2 hours, 3 hours and 4 hours of the rehydration period

  2. Plasma volume

    percent of plasma volume recovery during the rehydration

    Measured: at 30 minutes, 1 hour, 2 hours, 3 hours and 4 hours of the rehydration period

  3. Free water Clearance

    Free water clearance calculated based on plasma and urine osmolality

    Measured: at 30 minutes, 1 hour, 2 hours, 3 hours and 4 hours of the rehydration period

  4. Free Osmotic Clearance

    Free Osmotic clearance calculated based on plasma and urine osmolality

    Measured: at 30 minutes, 1 hour, 2 hours, 3 hours and 4 hours of the rehydration period

  5. Thirst

    Thirst estimated with a visual analog scale from 0-125 millimeters with higher value indicating greater perception

    Measured: at 30 minutes, 1 hour, 2 hours, 3 hours and 4 hours of the rehydration period

  6. Stomach fullness

    Stomach fullness estimated with a visual analog scale from 0-125 millimeters with higher value indicating greater perception

    Measured: at 30 minutes, 1 hour, 2 hours, 3 hours and 4 hours of the rehydration period

  7. Taste Likeness

    Taste Likeness estimated with a visual analog scale from 0-125 millimeters with higher value indicating greater perception

    Measured: at 30 minutes, 1 hour, 2 hours, 3 hours and 4 hours of the rehydration period

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted16 May 2024
  2. Study start21 May 2024
  3. Primary completion2 Dec 2024
  4. Study completion3 Dec 2024

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Other
Allocation
Randomised
Intervention model
Crossover
Masking
Single blind
Who is masked
Participant
Enrolment
20 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06414291
Sponsor's protocol ID
FP00039672
Acronym
LIV-D2O
Status last verified
Aug 2025
First submitted
7 May 2024
Last updated
28 Aug 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Plain Water, Liquid IV Hydration Multiplier and Liquid IV Sugar Free in people with Dehydration, run by Arizona State University at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 8 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 28 Aug 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Total fluid intake (time frame: 4 hours of rehydration). The study lists 10 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 28 Aug 2025.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in